Enhancing Utility of Neuropsychological Evaluation for Earlier and Effective Diagnosis of Dementia in Parkinson's Disease (PDCogniCare)

The University of Queensland

Status: Not yet enrolling

Conditions: Parkinson Disease Dementia (PDD); Dementia (Diagnosis); Parkinson Disease (PD)

Treatments: Other: PDCogniCare platform

Study type: Interventional

Funder types: Other

Identifiers

NCT07114354

HREC/2023/MNHA/100098

Details and patient eligibility

About

Dementia is observed in 80% of people living with advanced stage Parkinson's disease, however, there are inadequate opportunities for early and effective diagnosis of dementia in current clinical practice. This study aims to identify whether a new tool called PDCogniCare, can improve detection of dementia in people living with Parkinson's disease, and to explore what factors might influence its use in healthcare services.

Full description

The PDCogniCare tool integrates best practice guidelines for cognitive evaluations in people living with Parkinson's disease, along with a tailored digital platform to support guideline implementation and routinely track cognitive changes throughout the disease course. We hypothesize that PDCogniCare will significantly enhance cognitive evaluations within healthcare services. Embedded process and economics evaluations will inform implementation and sustainable business models of PDCogniCare.

Enrollment: 275 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• People living with idiopathic Parkinson's disease, one year or more post-diagnosis, attending Movement Disorder Clinics

Exclusion criteria

• People with severe Parkinson's disease who aren't able to communicate
• People with comorbid neurological conditions (e.g. Stroke)

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

275 participants in 1 patient group

PDCogniCare

Other group

Description:

All eligible people living with Parkinson's disease who consent to participate will be registered into the PDCogniCare platform.

Treatment:

Other: PDCogniCare platform